KIMBERLY BOVA: Open Payments
NPI 1841605078 · SUMMERVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,900 in 81 payments from 28 companies in 2025. Trend: 2023 $1,828 · 2024 $1,776 · 2025 $1,900
Food & beverage: $1,900
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 16 | $309 |
| PFIZER INC. | 11 | $189 |
| Medtronic, Inc. | 2 | $140 |
| Lilly USA, LLC | 8 | $132 |
| Eisai Inc. | 1 | $121 |
| Xeris Pharmaceuticals, Inc. | 2 | $109 |
| ACADIA Pharmaceuticals Inc | 1 | $106 |
| Novo Nordisk Inc | 5 | $89 |
| Phathom Pharmaceuticals, Inc. | 4 | $74 |
| Amgen Inc. | 4 | $62 |
Products named: MINIMED 780G, Leqembi, NUPLAZID, AIRSUPRA, MOUNJARO, FARXIGA, BREZTRI, KEVEYIS.
Industry payments across SC — which companies pay providers there.
